Literature DB >> 26837895

Enhanced humoral and cellular immune responses to PRRS virus GP5 glycoprotein by DNA prime-adenovirus boost vaccination in mice.

Meifang Yu1, Yuan Qiu1, Jiming Chen1, Wenming Jiang2.   

Abstract

In order to investigate the induction of humoral and cellular immune responses against porcine reproductive and respiratory syndrome virus (PRRSV), BALB/c mice were immunized in a pcDNA3-GP5 prime-rAd-GP5 boost regimen. After humoral and cellular immune response detection, levels of PRRSV-specific antibodies, neutralizing antibodies, lymphocyte proliferation response, and cytotoxic T-lymphocyte response were significantly increased as compared to controls. The humoral immune response was induced more effectively by the DNA priming and recombinant adenovirus boosting regimen. Significant difference was observed between heterogeneous and homologous vaccination. Induction of anti-GP5 antibody response was higher in all heterogeneous combinations than those of the homologous combinations. In the induction of lymphocyte proliferation response and CTL response, the homologous combination of pcDNA3-GP5/pcDNA3-GP5/pcDNA3-GP5was significantly stronger than that of rAd-GP5/rAd-GP5/rAd-GP5, but was relatively weaker than the heterogeneous combination of pcDNA3-GP5/pcDNA3-GP5/rAd-GP5 and pcDNA3-GP5/rAd-GP5/rAd-GP5. This heterogeneous combination was a most efficient immunization regimen in induction of PRRSV-specific cellular immune response just as the antibody response. These results suggested that DNA immunization followed by recombinant adenovirus boosting could be used as a potential PRRSV vaccine.

Entities:  

Keywords:  DNA vaccine; GP5 glycoprotein; PRRSV; Recombinant adenovirus

Mesh:

Substances:

Year:  2016        PMID: 26837895     DOI: 10.1007/s11262-016-1293-2

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  26 in total

1.  Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses.

Authors:  K Murata; A García-Sastre; M Tsuji; M Rodrigues; D Rodriguez; J R Rodriguez; R S Nussenzweig; P Palese; M Esteban; F Zavala
Journal:  Cell Immunol       Date:  1996-10-10       Impact factor: 4.868

2.  Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates of PRRSV.

Authors:  T Opriessnig; P G Halbur; K-J Yoon; R M Pogranichniy; K M Harmon; R Evans; K F Key; F J Pallares; P Thomas; X J Meng
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Humoral immune response induced by oral administration of S. typhimurium containing a DNA vaccine against porcine reproductive and respiratory syndrome virus.

Authors:  Ping Jiang; Wenming Jiang; Yufeng Li; Shengxie Wu; Jiarong Xu
Journal:  Vet Immunol Immunopathol       Date:  2004-12-08       Impact factor: 2.046

4.  T cell responses to the structural polypeptides of porcine reproductive and respiratory syndrome virus.

Authors:  E M Bautista; P Suárez; T W Molitor
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

Review 5.  DNA vaccination: antigen presentation and the induction of immunity.

Authors:  D J Shedlock; D B Weiner
Journal:  J Leukoc Biol       Date:  2000-12       Impact factor: 4.962

6.  Monoclonal antibodies to the ORF5 product of porcine reproductive and respiratory syndrome virus define linear neutralizing determinants.

Authors:  B Pirzadeh; S Dea
Journal:  J Gen Virol       Date:  1997-08       Impact factor: 3.891

7.  Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virus.

Authors:  William L Mengeling; Kelly M Lager; Ann C Vorwald; Kenneth J Koehler
Journal:  Vet Microbiol       Date:  2003-05-02       Impact factor: 3.293

8.  Emergence of a highly pathogenic porcine reproductive and respiratory syndrome virus in the Mid-Eastern region of China.

Authors:  Yufeng Li; Xinglong Wang; Kuntao Bo; Xianwei Wang; Bo Tang; Baoshou Yang; Wenming Jiang; Ping Jiang
Journal:  Vet J       Date:  2007-09-14       Impact factor: 2.688

Review 9.  Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development.

Authors:  X J Meng
Journal:  Vet Microbiol       Date:  2000-06-12       Impact factor: 3.293

10.  Adenoviral-expressed GP5 of porcine respiratory and reproductive syndrome virus differs in its cellular maturation from the authentic viral protein but maintains known biological functions.

Authors:  C A Gagnon; G Lachapelle; Y Langelier; B Massie; S Dea
Journal:  Arch Virol       Date:  2003-05       Impact factor: 2.574

View more
  2 in total

1.  Self-assembly of hexahistidine-tagged tobacco etch virus capsid protein into microfilaments that induce IgG2-specific response against a soluble porcine reproductive and respiratory syndrome virus chimeric protein.

Authors:  Carlos Alberto Manuel-Cabrera; Alba Adriana Vallejo-Cardona; Eduardo Padilla-Camberos; Rodolfo Hernández-Gutiérrez; Sara Elisa Herrera-Rodríguez; Abel Gutiérrez-Ortega
Journal:  Virol J       Date:  2016-11-29       Impact factor: 4.099

2.  A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection.

Authors:  Cindy Bernelin-Cottet; Céline Urien; Maxence Fretaud; Christelle Langevin; Ivan Trus; Luc Jouneau; Fany Blanc; Jean-Jacques Leplat; Céline Barc; Olivier Boulesteix; Mickaël Riou; Marilyn Dysart; Sophie Mahé; Elisabeth Studsrub; Hans Nauwynck; Nicolas Bertho; Olivier Bourry; Isabelle Schwartz-Cornil
Journal:  Viruses       Date:  2019-06-25       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.